Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 16th Ave E
Seattle, WA 98112Phone+1 206-326-3000
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 2016 - 2019
- Harvard Medical SchoolCertificate in Applied Biostatistics, 2017 - 2018
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2013 - 2016
- Boston University School of MedicineClass of 2013
- Boston University School of Public HealthMPH, Health Policy & Management, 2007 - 2009
- Tufts UniversityBA, English, Sociology, Pre-medical studies, Phi Beta Kappa, 2003 - 2007
Certifications & Licensure
- WA State Medical License 2019 - 2026
- MA State Medical License 2016 - 2020
- CA State Medical License 2014 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Chief Fellow 2018
- Interdisciplinary Autoimmune Summit Scholarship 2018
- AASLD Resident-Fellow Ambassador 2015
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEx Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer CellsRih-Sheng Huang, Min-Chi Lai, Steven Lin
Current Protocols. 2021-09-01 - 2 citationsThe functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain.Hsin-Hui Hsieh, Yen-An Chen, Yao-Jen Chang, Hsin-Hui Wang, Ya-Han Yu
Journal of Inflammation. 2021-06-05 - 27 citationsLRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons.Anwesha Sanyal, Hailey S. Novis, Emile Gasser, Steven C. Lin, Matthew J. LaVoie
Frontiers in Neuroscience. 2020-05-15
Journal Articles
- Infliximab in inflammatory bowel diseases6. Lin SC, Papamichael K, Moore M, Sattler L, Cheifetz AS, Therapeutic Advances in Chronic Disease., 10/2018
Press Mentions
- Will Telehealth Remain After COVID? Should It?August 28th, 2020
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Crohn's and Colitis FoundationMember
Other Languages
- Chinese (Mandarin), Taiwanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: